Dr. Rosa Bauer

Radiation oncologist · Hospital Clínic Barcelona · Spain (ES) · Oncology

Tier 1STK-0024GoodOwner MSL RARachel Adeyemi

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: SCLC
Scientific interests: PD-L1 biomarkersElderly patientsBrain metastases
Engagement preference: In person
Advisory boards: 3
Publications: 204
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 11 Feb 2026 (216 days ago)
Next planned contact: 13 May 2026 Overdue
Last 6 months vs target: 0%
0 of 2 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
11 Feb 2026	Scientific exchange	Phone	Rachel Adeyemi	Vantrexa	PD-L1 testing turnaroundSequencing after progression	0	—	Reviewed	ENG-0026

Timeline

11 Feb 2026
Scientific exchange
PD-L1 testing turnaround, Sequencing after progression

Related stakeholders (7)

Hospital Clínic Barcelona

Dr. Valentina Hayashi
Oncology pharmacist
Tier 2
Dr. Noor Abbott
Oncology pharmacist
Tier 2
Dr. Hiroshi Xu
Radiation oncologist
Tier 2
Dr. Benedikt Rossi
Primary care physician
Tier 3
Dr. Quentin Abbott
General neurologist
Tier 2
Dr. Chloé Ivanova
Headache specialist
Tier 1
Dr. Ingrid Bauer
General neurologist
Tier 1